Pneumonia in kidney allograft recipients

Area of Science:

• Nephrology
• Infectious Diseases
• Transplantation Immunology

Background:

• Infectious complications, particularly pneumonia, are major causes of illness and death in kidney transplant recipients.
• Understanding factors influencing pneumonia occurrence and treatment is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the relationship between pneumonia and various factors in kidney allograft recipients.
• To identify predictors of prolonged pneumonia treatment duration.

Main Methods:

• Retrospective analysis of 120 pneumonia cases in kidney allograft recipients transplanted between 1991 and 2000.
• Evaluation of recipient age, native kidney disease, dialysis duration, time to onset, HLA matching, immunosuppressive protocols, rejection, kidney function, and comorbidities.
• Analysis of treatment duration until antibiotic withdrawal.

Main Results:

• Pneumonia occurred throughout the post-transplant period, with significant episodes in the first month, 2-6 months, and 0.5-3 years.
• 50% of patients recovered within 15 days, and 75% within 24 days.
• Prolonged treatment was linked to second kidney transplants (RR=2.3), higher serum creatinine (>2 mg/dL, RR=1.4), enhanced-potency immunosuppression (RR=1.65), and non-cyclosporine maintenance (RR=2.18).

Conclusions:

• Pneumonia is a significant post-transplant complication with varied timing.
• Specific factors, including type of transplant, immunosuppression intensity, and renal function, influence pneumonia treatment duration.
• Risk stratification and tailored immunosuppression strategies may be necessary to mitigate pneumonia risks in kidney transplant recipients.